Laboratorio Of Citoimmunopatologia Apparato Cardio Respiratorio Fondazione Salvatore Maugeri

Veruno, Italy

Laboratorio Of Citoimmunopatologia Apparato Cardio Respiratorio Fondazione Salvatore Maugeri

Veruno, Italy
SEARCH FILTERS
Time filter
Source Type

Eleuteri E.,Laboratorio Of Citoimmunopatologia Apparato Cardio Respiratorio Fondazione Salvatore Maugeri | Di Stefano A.,Laboratorio Of Citoimmunopatologia Apparato Cardio Respiratorio Fondazione Salvatore Maugeri | Vallese D.,Laboratorio Of Citoimmunopatologia Apparato Cardio Respiratorio Fondazione Salvatore Maugeri | Gnemmi I.,Laboratorio Of Citoimmunopatologia Apparato Cardio Respiratorio Fondazione Salvatore Maugeri | And 7 more authors.
Biomarkers | Year: 2014

Background: Fibrosis suppressors/activators in chronic heart failure (CHF) is a topic of investigation. Aim: To quantify serum levels of fibrosis regulators in CHF. Methods: ELISA tests were used to quantify fibrosis regulators, procollagen type-(PIP)I, (PIP)III, collagen-I, III, BMP1,2,3,7, SDF1α, CXCR4, fibulin 1,2,3, BMPER, CRIM1 and BAMBI in 66 CHF (NYHA class I, n=9; II, n=34; III n=23), and in 14 controls. Results: In CHF, TGFβR2, PIPIII, SDF1α and CRIM1 were increased. PIPIII correlated with CRIM1. Conclusions: The BMPs inhibitor CRIM1 is increased and correlates with higher levels of serum PIPIII showing an imbalance in favor of pro-fibrotic mechanisms in CHF. © 2014 Informa UK Ltd. All rights reserved: reproduction in whole or part not permitted.

Loading Laboratorio Of Citoimmunopatologia Apparato Cardio Respiratorio Fondazione Salvatore Maugeri collaborators
Loading Laboratorio Of Citoimmunopatologia Apparato Cardio Respiratorio Fondazione Salvatore Maugeri collaborators